Dalmia Bharat Sugar & Industries Ltd
DALMIASUGDalmia Bharat Sugar & Industries Ltd's price has outrun its earnings. +12.4% in a year against EPS −35.2% — the market is paying now for delivery later.
The sharpest disagreement: the price moved +12.4% in a year while annual EPS moved −35.2% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is in a confirmed uptrend (6 weeks in) while the P/E sits at the 90th percentile of its own 11-year range. Underneath, the last four quarters read deteriorating — profit −82.4% year on year, and 45% of the last 3 years' profit arrived as cash. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Dalmia Bharat Sugar & Industries Ltd trades at ₹417, in a confirmed uptrend and 6 weeks into that stage. That is +12.4% against its own 200-day average. It sits at 64% of a 52-week range of ₹274 to ₹498. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 6 straight weeks.
Today the stock is in a confirmed uptrend — week 6 of stage 2, confirmed. At ₹417 it trades +12.4% versus its 200-day average and sits at 64% of its 52-week range (₹274–₹498).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +281% while the NIFTY 500 moved +259% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 6 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Dalmia Bharat Sugar & Industries Ltd trades at 16.5× P/E, at the pricey end of its own range (90th percentile). Its long-run median P/E is 10.1×, measured across 10.6 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 16.5× is at the pricey end of its own range (90th percentile), against a long-run median of 10.1× measured over 10.6 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
🚨 Why the multiple sits where it does: over the past year annual EPS moved −35.2% against a +12.4% price move — the price outran earnings, pushing the multiple UP its own range.
The price move, decomposed: over 5y, of the +0.2%/yr price move, ~−5.3%/yr came from earnings growth and ~+5.5 pp from the multiple (expanding); over 10y, of the +14.1%/yr price move, ~+15.3%/yr came from earnings growth and ~−1.2 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
What the price assumes This reading works the multiple backwards. It asks one question: what yearly rate of profit growth is a buyer at the market price already paying for? The number is the growth rate that makes eleven years of profit — six years growing, then five fading — add up to that day's market price, once each year is discounted at 11% a year.
Solved at its 13 June 2026 price, Dalmia Bharat Sugar & Industries Ltd was paying for profit growth of about 4.6% a year. Profit itself has compounded 15.1% a year over the past 10 years. Today the market pays 16.5× P/E, the 90th percentile of its own 11-year range.
What the two numbers say together. The multiple is full against its own past, and the growth the price is paying for is below what this company has actually delivered.
How to hold this number: it is a reading of one day's price, taken on 13 June 2026, not a running figure — every other number on this page, the multiple included, is read off the live quote as of 11 September 2026. A higher price is paying for more growth and a lower price for less, so it moves whenever the price does, and this page does not restate it between measurements.
Stage: Deteriorating Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Dalmia Bharat Sugar & Industries Ltd reads as deteriorating on its fundamental arc. Deteriorating — revenue, profit and EPS growth are shrinking (revenue growth −5.2% latest against +29.0% at its 12-quarter best), ROCE holding at 9.6%. The read is built from 12 quarters across 4 curves, on full evidence.
🚨 Why it matters: falling curves mean every cheap-looking ratio below needs a discount for direction.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | −2.9% | +3.6% | +6.1% | +12.0% |
| Profit | −35.5% | −1.9% | −2.7% | +15.1% |
| EPS | −35.2% | −1.8% | −2.6% | +15.0% |
| Share price | +12.4% | −0.1% | +0.2% | +14.1% |
4-Factor Sector Score
47.9/100 — rank 12 of 21 in Sugar · 100% evidence confidence
Dalmia Bharat Sugar & Industries Ltd scores 47.9 out of 100 against the 21 companies it is compared with in Sugar, ranking 12. Price leads the evidence: RS versus the benchmark is 22.6%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
The four contributions add to the total exactly: 7.2 + 9.9 + 12.9 + 17.9 = 47.9. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Dalmia Bharat Sugar & Industries Ltd reported ₹848 Cr of revenue in the Jun 26 quarter, −9.9% year on year. Over 10 years it has compounded at 12.0% a year. The last full year, FY26, came in at ₹3,617 Cr. The last four reported quarters add to ₹3,525 Cr.
FY26 revenue came in at ₹3,617 Cr (−2.9% on the year), capping 10 years at 12.0% compound. The latest quarter (Jun 26) printed ₹848 Cr, −9.9% year on year.
Pace check: the last four quarters averaged −5.6% growth against the decade's 12.0% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew −5.2% over the last 4 quarters against +7.9%/yr over the last 8 — rolling over; TTM profit −44.1% vs −12.6%/yr — rolling over.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Dalmia Bharat Sugar & Industries Ltd's operating margin is 5.1% in the Jun 26 quarter, −4.4 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 9.0% to 22.0%. The current quarter is running below every full year in that window.
The latest quarter's operating margin is 5.1%, −4.4 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 9.0%–22.0%.
🚨 Why the margin moved: operating margin went −4.4 pp year on year while gross margin went −2.5 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Dalmia Bharat Sugar & Industries Ltd earned ₹6.9 Cr of net profit in the Jun 26 quarter, −82.4% year on year. Full-year FY26 profit was ₹236 Cr. The 10-year compound rate is 15.1%. That is 0.8% of the quarter's revenue. The same quarter a year earlier earned ₹39.3 Cr.
Jun 26 profit was ₹6.9 Cr, −82.4% year on year. On the full year, FY26 printed ₹236 Cr (−35.5%), and the 10-year compound rate is 15.1%.
🚨 Why profit moved: revenue contributed −9.9% and the margin −4.4 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit −44.5% vs revenue −5.6%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 45% of Dalmia Bharat Sugar & Industries Ltd's reported profit arrived as operating cash — a gap worth watching. In FY26 that was ₹219 Cr of operating cash against ₹236 Cr of profit. After ₹124 Cr of capital spending, ₹95.0 Cr was left as free cash.
FY26: operating cash of ₹219 Cr against reported profit of ₹236 Cr, leaving free cash of ₹95.0 Cr after ₹124 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 45% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
🚨 Why conversion sits at 45%: the cash cycle held roughly steady between FY21 and FY26 — so conversion tracks profitability rather than the cycle. Less than 70% of profit arriving as cash is the thing to watch on this page.
Router verdict: no single sink dominates — the next section checks both the working-capital cycle and the capital spending.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Dalmia Bharat Sugar & Industries Ltd's cash conversion cycle runs 230 days in FY26, down from 237 days in FY21. Capital spending ran ₹552 Cr over the last 3 years. At FY26 sales of ₹3,617 Cr each day of that cycle holds about ₹9.9 Cr, so roughly ₹2,279 Cr sits inside the business at any moment.
FY26: debtors at 18 days, inventory at 233 days — roughly 7.7 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 230 days, tighter than FY21's 237.
The full loop: cash goes out to suppliers and production on day 0; stock waits 233 days to sell; customers pay about 18 days after that; and suppliers themselves are paid at 21 days — netting out to the 230-day cycle.
In money terms: at FY26 sales of ₹3,617 Cr, each day of the cycle holds about ₹9.9 Cr — so the 230-day loop keeps roughly ₹2,279 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹552 Cr over the last 3 fiscal years against ₹394 Cr of depreciation — building somewhat ahead of wear-and-tear. Capital work-in-progress stands at ₹47.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: neither the cycle nor the build-out is hoarding the cash — the machine is reasonably clean.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Dalmia Bharat Sugar & Industries Ltd earns a ROCE of 8% in FY26. That is up from a trough of 5% in FY15. Return on invested capital clears the cost of that capital by −7.7 percentage points, so growth here is not yet paying for the capital it uses.
FY26 ROCE is 8%, recovered from a FY15 trough of 5% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY26): 6.5% net margin × 0.66× asset turns × 1.70× balance-sheet leverage ≈ 7.3% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 4.3% − 12.0% = a −7.7 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Dalmia Bharat Sugar & Industries Ltd carries total debt of ₹1,803 Cr against shareholder equity of ₹3,235 Cr as of Mar 26, a debt-to-equity of 0.56. On the annual view that ratio went from 0.35 in FY22 to 0.56 in FY26. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of ₹1,803 Cr against shareholder equity of ₹3,235 Cr — a debt-to-equity of 0.56. On the annual view, debt-to-equity went from 0.35 (FY22) to 0.56 (FY26). Read the returns on this page with that leverage in mind.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
No holder of Dalmia Bharat Sugar & Industries Ltd moved a full percentage point over the last two years — the register is quiet. Domestic institutions moved +0.2 points over the same window, to 0.3%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Foreign institutions: −0.4 points over 8 quarters to 0.5%; Domestic institutions: +0.2 points over 8 quarters to 0.3%; Promoters: +0.0 points over 8 quarters to 74.9%.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Dalmia Bharat Sugar & Industries Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Andhra Sugars LtdANDHRSUGAR | 73.8/100Favorable setup87% evidence | BREAKING OUT | 31.7/35 Revenue 16.5% · PAT 100% · OPM change 3 pp 95% evidence | 14.8/25 ROCE 8.4% · OPM 12% 95% evidence | 12.9/20 P/E 11.1× · PEG — 50% evidence | 14.4/20 RS sector 6.8% · RS bench 19.6% · 1Y 25.7%6 of 12 weeks ahead 100% evidence |
| Exact sum: 31.7 + 14.8 + 12.9 + 14.4 = 73.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2DCM Shriram LtdDCMSHRIRAM | 61.0/100Mixed-positive evidence100% evidence | BASING | 24.3/35 Revenue 11.1% · PAT 100% · OPM change 0 pp 100% evidence | 14.7/25 ROCE 11.5% · OPM 9% 100% evidence | 18.3/20 P/E 11.4× · PEG 0.44 100% evidence | 3.7/20 RS sector -20.5% · RS bench -10.3% · 1Y -19.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 24.3 + 14.7 + 18.3 + 3.7 = 61 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -20.5% and the one-year return is -19.6%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 3Ugar Sugar Works LtdUGARSUGAR | 60.2/100Thin evidence · provisional59% evidence | 26.9/35 Revenue 17.2% · PAT 100% · OPM change 4.1 pp 71% evidence | 10.5/25 ROCE 9% · OPM 5.6% 76% evidence | 10.6/20 P/E 21.2× · PEG — 50% evidence | 12.2/20 RS sector — · RS bench 31.2% · 1Y — 25% evidence | |
| Exact sum: 26.9 + 10.5 + 10.6 + 12.2 = 60.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 4Dhampur Sugar Mills LtdDHAMPURSUG | 56.9/100Mixed-positive evidence87% evidence | BREAKING OUT | 21.3/35 Revenue 1.3% · PAT 36.3% · OPM change 1.3 pp 95% evidence | 9.8/25 ROCE 6.4% · OPM 5.7% 95% evidence | 10.0/20 P/E 15× · PEG — 50% evidence | 15.8/20 RS sector 8% · RS bench 20.9% · 1Y 19%5 of 12 weeks ahead 100% evidence |
| Exact sum: 21.3 + 9.8 + 10 + 15.8 = 56.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Uttam Sugar Mills LtdUTTAMSUGAR | 52.1/100Mixed-positive evidence74% evidence | BREAKING OUT | 16.5/35 Revenue 7.8% · PAT -7.6% · OPM change -3.7 pp 95% evidence | 15.2/25 ROCE 11.4% · OPM 4.3% 95% evidence | 10.9/20 P/E 12.1× · PEG — 15% evidence | 9.5/20 RS sector -9.1% · RS bench 17.4% · 1Y 5.8%5 of 10 weeks ahead 70% evidence |
| Exact sum: 16.5 + 15.2 + 10.9 + 9.5 = 52.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6M.V.K. Agro Food Product LtdMVKAGRO | 52.1/100Thin evidence · provisional57% evidence | BASING | 13.3/35 Revenue — · PAT — · OPM change -7.5 pp 45% evidence | 17.5/25 ROCE 14.4% · OPM 10.8% 95% evidence | 9.6/20 P/E 30.5× · PEG — 15% evidence | 11.7/20 RS sector 33.8% · RS bench -40.7% · 1Y -19%0 of 10 weeks ahead 70% evidence |
| Exact sum: 13.3 + 17.5 + 9.6 + 11.7 = 52.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 7Triveni Engineering and Industries LtdTRIVENI | 51.9/100Mixed-positive evidence82% evidence | BREAKING OUT | 21.8/35 Revenue 4% · PAT 29.1% · OPM change 1 pp 95% evidence | 12.2/25 ROCE 9% · OPM 3.4% 76% evidence | 8.0/20 P/E 21.5× · PEG — 50% evidence | 9.9/20 RS sector -1.3% · RS bench 10.7% · 1Y 16%8 of 12 weeks ahead 100% evidence |
| Exact sum: 21.8 + 12.2 + 8 + 9.9 = 51.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Avadh Sugar & Energy LtdAVADHSUGAR | 51.9/100Mixed-positive evidence79% evidence | BREAKING OUT | 14.5/35 Revenue 4.2% · PAT -6.9% · OPM change 0.7 pp 71% evidence | 10.1/25 ROCE 6.8% · OPM 4.7% 95% evidence | 7.3/20 P/E 22.9× · PEG — 50% evidence | 20.0/20 RS sector 51.4% · RS bench 68.4% · 1Y 69.5%9 of 12 weeks ahead 100% evidence |
| Exact sum: 14.5 + 10.1 + 7.3 + 20 = 51.9 · Decision use: Price leads the evidence: RS versus the benchmark is 68.4%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 9EID Parry (India) LtdEIDPARRY | 50.3/100Mixed-positive evidence76% evidence | TURNING | 17.5/35 Revenue 15.7% · PAT -38.9% · OPM change -1 pp 95% evidence | 18.0/25 ROCE 17% · OPM 8% 76% evidence | 10.3/20 P/E 15.8× · PEG — 50% evidence | 4.5/20 RS sector -20.5% · RS bench -16.7% · 1Y -35.2%1 of 10 weeks ahead 70% evidence |
| Exact sum: 17.5 + 18 + 10.3 + 4.5 = 50.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Balrampur Chini Mills LtdBALRAMCHIN | 50.0/100Mixed-positive evidence100% evidence | BREAKING OUT | 15.6/35 Revenue 15% · PAT -11.2% · OPM change -2 pp 100% evidence | 13.3/25 ROCE 9.3% · OPM 7% 100% evidence | 2.2/20 P/E 39.4× · PEG 2.21 100% evidence | 18.9/20 RS sector 22.8% · RS bench 37.4% · 1Y 25.8%11 of 12 weeks ahead 100% evidence |
| Exact sum: 15.6 + 13.3 + 2.2 + 18.9 = 50 · Decision use: Price leads the evidence: RS versus the benchmark is 37.4%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 11Dhampur Bio Organics LtdDBOL | 50.0/100Mixed-positive evidence72% evidence | BREAKING OUT | 21.5/35 Revenue 8% · PAT 100% · OPM change -0.1 pp 71% evidence | 7.2/25 ROCE 5% · OPM 1.7% 95% evidence | 9.4/20 P/E 30.8× · PEG — 15% evidence | 11.9/20 RS sector 7.7% · RS bench 20.4% · 1Y 39%3 of 12 weeks ahead 100% evidence |
| Exact sum: 21.5 + 7.2 + 9.4 + 11.9 = 50 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Dalmia Bharat Sugar & Industries Ltdthis pageDALMIASUG | 47.9/100Mixed-negative evidence100% evidence | BREAKING OUT | 7.2/35 Revenue -5.2% · PAT -44.1% · OPM change -4.4 pp 100% evidence | 9.9/25 ROCE 8.2% · OPM 5.1% 100% evidence | 12.9/20 P/E 16.5× · PEG 0.55 100% evidence | 17.9/20 RS sector 9.7% · RS bench 22.6% · 1Y 9.7%5 of 12 weeks ahead 100% evidence |
| Exact sum: 7.2 + 9.9 + 12.9 + 17.9 = 47.9 · Decision use: Price leads the evidence: RS versus the benchmark is 22.6%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 13Zuari Industries LtdZUARIIND | 39.9/100Mixed-negative evidence66% evidence | TURNING | 16.1/35 Revenue 9.7% · PAT 100% · OPM change -5.3 pp 71% evidence | 7.6/25 ROCE 5.5% · OPM 4.5% 95% evidence | 11.5/20 P/E 7× · PEG — 15% evidence | 4.7/20 RS sector -26.8% · RS bench -1.7% · 1Y -9.1%4 of 10 weeks ahead 70% evidence |
| Exact sum: 16.1 + 7.6 + 11.5 + 4.7 = 39.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Magadh Sugar & Energy LtdMAGADSUGAR | 38.8/100Mixed-negative evidence79% evidence | BREAKING OUT | 8.2/35 Revenue -5.7% · PAT -46.9% · OPM change -5.8 pp 71% evidence | 8.5/25 ROCE 7.8% · OPM 0.2% 95% evidence | 9.4/20 P/E 14.8× · PEG — 50% evidence | 12.7/20 RS sector -1.5% · RS bench 10.6% · 1Y -4.3%5 of 12 weeks ahead 100% evidence |
| Exact sum: 8.2 + 8.5 + 9.4 + 12.7 = 38.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Davangere Sugar Company LtdDAVANGERE | 37.1/100Mixed-negative evidence70% evidence | 14.3/35 Revenue 11.1% · PAT -22.3% · OPM change -6.9 pp 83% evidence | 10.3/25 ROCE 5.6% · OPM 10.1% 95% evidence | 8.5/20 P/E 58.6× · PEG — 15% evidence | 4.0/20 RS sector -25% · RS bench -12.6% · 1Y -12.3%0 of 2 weeks ahead to 2026-07-19 70% evidence | |
| Exact sum: 14.3 + 10.3 + 8.5 + 4 = 37.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Bannari Amman Sugars LtdBANARISUG | 35.4/100Mixed-negative evidence100% evidence | ASLEEP | 11.0/35 Revenue -7.6% · PAT 8% · OPM change -12 pp 100% evidence | 10.2/25 ROCE 8.8% · OPM -3% 100% evidence | 9.3/20 P/E 36.2× · PEG 1.75 100% evidence | 4.9/20 RS sector -12.1% · RS bench -1.1% · 1Y -3.7%2 of 12 weeks ahead 100% evidence |
| Exact sum: 11 + 10.2 + 9.3 + 4.9 = 35.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Godavari Biorefineries LtdGODAVARIB | 35.1/100Mixed-negative evidence72% evidence | BASING | 18.0/35 Revenue 7% · PAT 100% · OPM change -1 pp 71% evidence | 7.2/25 ROCE 6.5% · OPM 0.1% 95% evidence | 8.8/20 P/E 41.2× · PEG — 15% evidence | 1.1/20 RS sector -24% · RS bench -14.6% · 1Y -17.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18 + 7.2 + 8.8 + 1.1 = 35.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Bajaj Hindusthan Sugar LtdBAJAJHIND | 32.0/100Adverse evidence78% evidence | TURNING | 12.8/35 Revenue -1.9% · PAT 100% · OPM change -8.9 pp 74% evidence | 1.2/25 ROCE 3.1% · OPM -11% 100% evidence | 10.3/20 P/E 38.6× · PEG 1.32 65% evidence | 7.7/20 RS sector -21% · RS bench 12.8% · 1Y -1%4 of 11 weeks ahead 70% evidence |
| Exact sum: 12.8 + 1.2 + 10.3 + 7.7 = 32 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Shree Renuka Sugars LtdRENUKA | 28.7/100Adverse evidence71% evidence | TURNING | 10.0/35 Revenue -5.1% · PAT -80% · OPM change 0.7 pp 74% evidence | 0.5/25 ROCE -3.1% · OPM -3.6% 100% evidence | 10.0/20 P/E — · PEG — 0% evidence | 8.2/20 RS sector -12.8% · RS bench -1.8% · 1Y -22.6%2 of 12 weeks ahead 100% evidence |
| Exact sum: 10 + 0.5 + 10 + 8.2 = 28.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20Dwarikesh Sugar Industries LtdDWARKESH | 28.4/100Adverse evidence72% evidence | TURNING | 9.6/35 Revenue -4.8% · PAT -45.8% · OPM change -8 pp 71% evidence | 2.5/25 ROCE 4.6% · OPM -7% 95% evidence | 8.7/20 P/E 57.2× · PEG — 15% evidence | 7.6/20 RS sector -3.4% · RS bench 8.2% · 1Y 0.4%2 of 12 weeks ahead 100% evidence |
| Exact sum: 9.6 + 2.5 + 8.7 + 7.6 = 28.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 21DCM Shriram Industries LtdDCMSRIND | 43.3/100Thin evidence · provisional48% evidence | 12.5/35 Revenue -3.7% · PAT -50% · OPM change -6.8 pp 45% evidence | 14.6/25 ROCE 13.7% · OPM 1.8% 71% evidence | 8.4/20 P/E 8.2× · PEG — 50% evidence | 7.8/20 RS sector — · RS bench -16.3% · 1Y — 25% evidence | |
| Exact sum: 12.5 + 14.6 + 8.4 + 7.8 = 43.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Dalmia Bharat Sugar & Industries Ltd's share price today?
Dalmia Bharat Sugar & Industries Ltd trades at ₹417, +12.4% over the past year. The company is valued at ₹3,378 Cr. The stock sits at 64% of its 52-week range of ₹274–₹498, +12.4% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 6 weeks in. — as of 11 September 2026.
What were Dalmia Bharat Sugar & Industries Ltd's latest quarterly results?
Dalmia Bharat Sugar & Industries Ltd reported revenue of ₹848 Cr and net profit of ₹6.9 Cr for the Jun 26 quarter. Revenue fell 9.9% and profit fell 82.4% year on year. Earnings per share were ₹0.95. The operating margin was 5.1%, 4.4 pp lower than a year earlier. — as of 11 September 2026.
What is Dalmia Bharat Sugar & Industries Ltd's revenue?
Dalmia Bharat Sugar & Industries Ltd reported revenue of ₹848 Cr in the Jun 26 quarter, −9.9% year on year. For the full FY26 fiscal year, revenue was ₹3,617 Cr (−2.9%). Over the last 10 years revenue compounded at 12.0% a year. — as of 11 September 2026.
What is Dalmia Bharat Sugar & Industries Ltd's profit?
Dalmia Bharat Sugar & Industries Ltd earned ₹6.9 Cr of net profit in the Jun 26 quarter, −82.4% year on year. Full-year FY26 profit was ₹236 Cr. The operating margin ran 5.1% in the latest quarter. — as of 11 September 2026.
What is Dalmia Bharat Sugar & Industries Ltd's market cap?
Dalmia Bharat Sugar & Industries Ltd's market capitalisation is ₹3,378 Cr at a share price of ₹417. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
What is Dalmia Bharat Sugar & Industries Ltd's P/E ratio?
Dalmia Bharat Sugar & Industries Ltd trades at a P/E of 16.5×, at the 90th percentile of its own 11-year range, against a long-run median of 10.1×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.
Does Dalmia Bharat Sugar & Industries Ltd pay a dividend?
Yes — Dalmia Bharat Sugar & Industries Ltd's dividend payout was 21% of profit in FY26, and it recorded a payout in 11 of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 11 September 2026.
Is Dalmia Bharat Sugar & Industries Ltd overvalued?
On its own history, Dalmia Bharat Sugar & Industries Ltd looks expensive: its P/E of 16.5× sits at the 90th percentile of its 11-year range (long-run median 10.1×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.
Is Dalmia Bharat Sugar & Industries Ltd growing?
Not right now — Dalmia Bharat Sugar & Industries Ltd's latest numbers are shrinking: latest-quarter revenue −9.9% year on year, profit −82.4%, and the margin −4.4 pp at 5.1%. The 10-year compound rates are 12.0% (revenue) and 15.1% (profit). The earnings engine currently reads: deteriorating — as of 11 September 2026.
How is Dalmia Bharat Sugar & Industries Ltd performing?
Dalmia Bharat Sugar & Industries Ltd is in a confirmed uptrend, 6 weeks in. Its latest quarter's revenue fell 9.9% and profit fell 82.4% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 6 weeks. — as of 11 September 2026.
What stage is Dalmia Bharat Sugar & Industries Ltd in?
Deteriorating — revenue, profit and EPS growth are shrinking (revenue growth −5.2% latest against +29.0% at its 12-quarter best), ROCE holding at 9.6%. The read comes from the last 12 quarters of growth (revenue growth −5.2% latest, profit growth −44.1% latest, eps growth −43.6% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.
Is Dalmia Bharat Sugar & Industries Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 6 of stage 2), trading +12.4% versus its 200-day average and at 64% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is Dalmia Bharat Sugar & Industries Ltd beating the market?
On recent form, yes — Dalmia Bharat Sugar & Industries Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 6 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +281% against the NIFTY 500's +259% — ahead of the index over the full window. — as of 11 September 2026.
Will Dalmia Bharat Sugar & Industries Ltd's share price go up?
This page publishes no price forecast for Dalmia Bharat Sugar & Industries Ltd. What it measures instead: the share price is ₹417, the price is in a confirmed uptrend 6 weeks in. Its P/E of 16.5× sits at the 90th percentile of its own 11-year range. — as of 11 September 2026.
Who owns Dalmia Bharat Sugar & Industries Ltd?
Promoters hold 74.9% of Dalmia Bharat Sugar & Industries Ltd, foreign institutions 0.5%, domestic institutions 0.3% and the public 24.1% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 11 September 2026.
Does Dalmia Bharat Sugar & Industries Ltd have too much debt?
It is moderate — Dalmia Bharat Sugar & Industries Ltd's debt-to-equity is 0.56, and operating profit covers the interest bill 7×. FY26 borrowings were ₹1,803 Cr against equity of ₹3,242 Cr. Read the returns on this page with that leverage in mind — as of 11 September 2026.
What is Dalmia Bharat Sugar & Industries Ltd's capex?
Dalmia Bharat Sugar & Industries Ltd spent ₹552 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹124 Cr, with ₹47.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.
What is Dalmia Bharat Sugar & Industries Ltd's cash flow?
Dalmia Bharat Sugar & Industries Ltd generated ₹219 Cr of operating cash flow in FY26 and ₹95.0 Cr of free cash flow after ₹124 Cr of capital spending. Reported profit that year was ₹236 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 11 September 2026.
Is Dalmia Bharat Sugar & Industries Ltd's profit real cash?
Not fully — over the last 3 fiscal years, 45% of Dalmia Bharat Sugar & Industries Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹219 Cr against reported profit of ₹236 Cr. The cash then goes into a mix of the working-capital cycle and capacity. Cash-flow resolution is annual — as of 11 September 2026.
Where is Dalmia Bharat Sugar & Industries Ltd in its business cycle?
Dalmia Bharat Sugar & Industries Ltd's FY26 operating margin was 12.0%, against a 13-year band of 9.0%–22.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 5.1%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What growth does Dalmia Bharat Sugar & Industries Ltd's price assume?
At its price on 13 June 2026, Dalmia Bharat Sugar & Industries Ltd was priced for profit growth of about 4.6% a year. Profit itself has compounded 15.1% a year over the past 10 years. The figure reads the multiple backwards: the growth a buyer at that price was already paying for. — as of 11 September 2026.
What could break the Dalmia Bharat Sugar & Industries Ltd story?
The sharpest disagreement: the price moved +12.4% in a year while annual EPS moved −35.2% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is Dalmia Bharat Sugar & Industries Ltd a stock worth studying right now?
This is not investment advice. The machine read: Dalmia Bharat Sugar & Industries Ltd's price has outrun its earnings. +12.4% in a year against EPS −35.2% — the market is paying now for delivery later. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!